Dibasol (Dibazol)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceBendazoleBendazole
Similar drugsTo uncover
  • Bendazole
    solution w / m in / in 
    FARMZASCHITA NPC, FSUE     Russia
  • Dibasol
    solution w / m in / in 
    ATOLL, LLC     Russia
  • Dibasol
    solution w / m in / in 
    MOSHIMFARM PREPARATES them.N.А.Semashko, OJSC     Russia
  • Dibasol
    solution w / m in / in 
    NOVOSIBHIMFARM, OJSC     Russia
  • Dibasol
    solution w / m in / in 
    DALHIMFARM, OJSC     Russia
  • Dibasol
    solution w / m in / in 
    BORISOVSKIY FACTORY OF MEDPREPARATES, OJSC     Republic of Belarus
  • Dibasol
    solution w / m in / in 
    VELFARM, LLC     Republic of San Marino
  • Dibazol-Vial
    solution w / m in / in 
    VIAL, LLC     Russia
  • Dibazol-Darnitsa
    solution w / m in / in 
    DARNITSA PHARMACEUTICAL FIRM, CJSC     Ukraine
  • Dibasol-UBF
    pills inwards 
    URALBIOFARM, OJSC     Russia
  • Dibazole tablets 0.02 g
    pills inwards 
    TsNKB FSUE     Russia
    • Dosage form: & nbspsolution for intravenous and intramuscular administration
    Composition:
    Composition per ml:
    Active substance: bendazole hydrochloride 10.0 mg
    Excipients:
    glycerol - 108.0 mg
    ethanol 95% -0.1 ml
    hydrochloric acid 0.1 M - 0.01 ml
    water for injection - up to 1.0 ml.
    ATX: & nbsp

    C.04.A.X   Other peripheral vasodilators

    Contraindications:
    Hypersensitivity to bendazole and other components of the drug; diseases accompanied by increased muscle tone or convulsive syndrome, age to 18 years.
    Pregnancy and lactation:
    Because there is no safety data for the fetus, it can not be used during pregnancy.
    It is not known whether benzazole in breast milk.During lactation, the issue of stopping breastfeeding during the treatment with Dibazol should be resolved.
    Side effects:
    The incidence of unwanted reactions is described in accordance with the following gradation: very often> 1/10, often from> 1/100 to <1/10, infrequently from> 1/1000 to <1/100.
    From the central nervous system: often - dizziness, slight headache.
    From the digestive system: infrequently - nausea.
    Local reactions (together with administration): very often - soreness in the injection site.
    Other: often - increased sweating, a feeling of heat, infrequently - allergic reactions.
    When the dose is lowered or the drug is withdrawn, these side effects quickly disappear.
    Overdose:No information.
    Special instructions:
    Do not apply for prolonged treatment of hypertension, especially in elderly patients, since the antihypertensive effect is associated with a decrease in cardiac output and possibly a deterioration in the electrocardiogram score.
    Effect on the ability to drive transp. cf. and fur:
    Care must be taken when driving vehicles and working with other mechanisms,requiring increased concentration of attention and speed of psychomotor reactions (risk of developing dizziness and headache).
    Form release / dosage:
    Solution for intravenous and intramuscular injection 10 mg / ml.
    Packaging:
    1 ml, 2 ml or 5 ml in ampoules of colorless neutral glass type I with a color fracture ring or with a colored dot and a notch or without a rupture ring, a colored dot and a notch. One, two or three color rings and / or a two-dimensional bar code, and / or alphanumeric coding or without additional color rings, a two-dimensional bar code, and alphanumeric coding can additionally be applied to the ampoules.
    5 ampoules per circuit cell packaging made of polyvinylchloride film and aluminum foil foil or polymer film or without foil and without film.
    Or 5 ampoules are placed a prefabricated form (tray) made of cardboard with cells for laying ampoules.
    1 or 2 contour squares or cardboard trays, together with the instruction for use and the ampoule ampoule or ampoule ampoule or without a knife ampoule and scarifier ampoules are placed in cardboard packing (bundle).
    Storage conditions:
    At temperatures from +5 to +30 ° С.
    Keep out of the reach of children.
    Terms of leave from pharmacies:On prescription
    Registration number:P N000861 / 02
    Date of registration:05.09.2008
    The owner of the registration certificate:ATOLL, LLC ATOLL, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp02.12.2013
    Illustrated instructions
      Instructions
      Up